Form 8-K - Current report:
SEC Accession No. 0000950123-10-035821
Filing Date
2010-04-19
Accepted
2010-04-19 12:45:32
Documents
6
Period of Report
2010-04-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K b80597e8vk.htm 8-K 31251
2 EX-2.1 b80597exv2w1.htm EX-2.1 348246
3 EX-10.1 b80597exv10w1.htm EX-10.1 103013
4 EX-99.1 b80597exv99w1.htm EX-99.1 3890
5 EX-99.2 b80597exv99w2.htm EX-99.2 15374
6 GRAPHIC b80597b8059701.gif GRAPHIC 11832
  Complete submission text file 0000950123-10-035821.txt   520220
Mailing Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617-349-4500
JAVELIN PHARMACEUTICALS, INC (Filer) CIK: 0000050710 (see all company filings)

EIN.: 880471759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32949 | Film No.: 10756718
SIC: 2834 Pharmaceutical Preparations